No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations
Preprint
- 27 November 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion, which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care, individuals on immunosuppressive drugs, and healthy adults. Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was not associated with increased T cell exhaustion in older frail adults, immunosuppressed individuals, or healthy adults.Keywords
All Related Versions
- Version 1, 2024-11-27, Research Square
- Published version: Nature Communications, 16 (1), 1.
This publication has 38 references indexed in Scilit:
- Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort studyJournal of Medical Virology, 2023
- Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal studyInternational Journal of Infectious Diseases, 2022
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationCell, 2022
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineCell, 2021
- PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19Immunity, 2021
- COMPASS identifies T-cell subsets correlated with clinical outcomesNature Biotechnology, 2015
- Properties of end-stage human T cells defined by CD45RA re-expressionCurrent Opinion in Immunology, 2012
- CD28− T cells: their role in the age-associated decline of immune functionTrends in Immunology, 2009
- T-cell quality in memory and protection: implications for vaccine designNature Reviews Immunology, 2008
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007